AptarGroup, Inc. (NYSE: ATR), a global leader in drug delivery and consumer product dosing, dispensing and protection ...
In this webinar, Andre Mueller will discuss how scientists characterize therapeutic proteins in different formulations and ...
With Spanberger taking office, lawmakers reconvene this week to tackle abortion, voting rights, redistricting and a new state ...
8hOpinion
Opinion: Venezuela’s turmoil, India’s tightrope—why New Delhi must put interests before impulses
Venezuela’s turmoil is a reminder that foreign policy is about steering one’s own ship while navigating global storms ...
Opinion
5hOpinion
Quantum Computing Threatens Digital Security: The Urgent Need for Post-Quantum Cryptography
Quantum computing poses a real and growing threat to established cryptographic algorithms like RSA and Elliptic Curve Cryptography (ECC), which form the backbone of digital security for DLT networks ...
The President held a working meeting with First Deputy Prime Minister Denis Manturov. The discussion focused on last year’s ...
New options for testing and treating some of the most common sexually transmitted diseases are becoming available.
Some antibiotics stop bacteria from growing without actually killing them, allowing infections to return later. Scientists at ...
Following initiation of elexacaftor/tezacaftor/ivacaftor, Lung Clearance Index decreases in children with cystic fibrosis, ...
A new study co-written by a University of Illinois Urbana-Champaign expert in operations management finds that drugs approved ...
AptarGroup, Inc. , a global leader in drug delivery and consumer product dosing, dispensing and protection technologies, today shared an overview of its growing portfolio of eye care solutions ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback